The Valley Desk

NCT06292013 · Interventional trial

A Study to Investigate the Effect of Lepodisiran on the Reduction of Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) - ACCLAIM-Lp(a)

Overall registry status Active not recruiting

Phase 3

Conditions Atherosclerotic Cardiovascular Disease (ASCVD), Elevated Lp(a)

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov